Tristan Medical Enterprises, PC dba Regeneris — North Attleboro, Massachusetts

Tristan Medical Enterprises, PC dba Regeneris is a clinical research site located in North Attleboro, Massachusetts, United States 02760.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Tristan Medical Enterprises, PC dba Regeneris has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Attleboro

Browse all research sites in Massachusetts · View every site in North Attleboro

• Regeneris Medical
• Research Site
• Tristan Medical Enterprises, PC dba Regeneris Medical
• Velicept Investigative Site - North Attleborro
• Tristan Medical Enterprises PC, dba
• Investigational Site
• US040 - Regeneris Medical
• Tristan Medical Research Center / Regeneris Medical

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tristan Medical Enterprises, PC dba Regeneris?

Tristan Medical Enterprises, PC dba Regeneris has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tristan Medical Enterprises, PC dba Regeneris conducted?

Tristan Medical Enterprises, PC dba Regeneris has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Tristan Medical Enterprises, PC dba Regeneris accredited by Crixeo Clinical Trials?

Tristan Medical Enterprises, PC dba Regeneris has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tristan Medical Enterprises, PC dba Regeneris?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.